Skin and Connective Tissue Diseases clinical trials

The registry lists 20 studies for Skin and Connective Tissue Diseases across more than 10 countries. 6 are recruiting or about to start. 5 of them are mainly about Skin and Connective Tissue Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-28. Counting its 226 narrower conditions too, such as Breast Neoplasms: 49,984 studies, 9,970 open.

Get an email when these change. Save the Skin and Connective Tissue Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 11
Recruiting: 3
Active, not recruiting: 2
Not yet recruiting: 2
Enrolling by invitation: 1
Withdrawn: 1

Phase

Phase 1: 8
Phase 2: 6
Phase 4: 3
Early Phase 1: 1
Phase 3: 1

Where

Germany: 7
France: 4
United States: 3
Bulgaria: 3
Belgium: 2
Poland: 2

Who runs them

LEO Pharma (4) · UCB Pharma (2) · Premier Specialists, Australia (1) · GWT-TUD GmbH (1) · CENTOGENE GmbH Rostock (1) · NeuroGT (1) · Aarhus University Hospital (1) · Pfizer (1)

What is being tested here

Drugs under test in Skin and Connective Tissue Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Cenerimod	1	1	1
Dapirolizumab pegol	0	0	2
LEO 90100	0	0	1
Clobetasol	0	0	1
Betamethasone dipropionate	0	0	1
Betamethasone	0	0	1
Tildrakizumab	0	0	1
Secukinumab	0	0	1
Emodepside	0	0	1
Linezolid	0	0	1

Coming up

1phase 3 study under way

1study finishes main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The study

Oct 2027A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial) · Spyre Therapeutics, Inc.

Who these studies take

Of the 3 Skin and Connective Tissue Diseases studies recruiting now, 2 (67%) set no upper age limit and 1 (33%) stop at 75 or younger. 1 (33%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 3
Age	Women	Men
10	1 (33%)	1 (33%)
18	3 (100%)	3 (100%)
30	3 (100%)	3 (100%)
40	3 (100%)	3 (100%)
50	3 (100%)	3 (100%)
65	3 (100%)	3 (100%)
75	3 (100%)	3 (100%)
85	2 (67%)	2 (67%)

Across all 20 studies, recruiting or not: 40% stop at 75 or younger and 25% at 65; 20% take children; 0% are for women only and 15% for men only; 30% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 15, 2026.

Started recruiting1

A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)Oct 19, 2026NCT07766005

Studies

Recruiting first, then most recently updated. Showing 20 of 20. search them.